News - 2008

1. December 18, 2008
   VistaGen and WARF Sign License Agreement for Human Embryonic Stem Cell Technology
   
   
2. December 16, 2008
   VistaGen Receives Significant Stem Cell Tools and Technologies Grant from California Institute for Regenerative Medicine
   
   
3. October 16, 2008
   VistaGen Team Pinpoints Key Biochemical Pathways Involved in Generating ES cell-derived Heart Cells
   
   
4. June 17, 2008
   New Broad Composition of Matter Patent Protects VistaGen.s ES Cell Applications
   
   
5. May 22, 2008
   VistaGen Licenses Customized Stem Cell-Based Drug Discovery Assays to Sanwa, a Japanese
   Pharmaceutical Company
   
   
6. April 23, 2008
   VistaGen Collaborates with Canadian, U.S., and British Researchers To Isolate Earliest Embryonic
   Stem Cell-Derived Human Cardiac Cell
   
7. March 21, 2008
   Early warning system for drug dangers sought More...
   
   
8. March 12, 2008
   VistaGen Therapeutics Announces Broad Stem Cell R&D Alliance With Toronto's University
   Health Network and The McEwen Centre For Regenerative Medicine   More...
   
   
   

Events

1. March 17, 2008
   H. Ralph Snodgrass, President & CEO, VistaGen Therapeutics, Inc.
   BioNetwork East 2008, Naples, FL  More...